Nature's Miracle Holding Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Nature's Miracle Holding Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2023
FY2024
FY2025
Revenue
18.6
8.93
9.26
1.74
Cost of revenue
17
9.88
12.1
2.19
Gross profit
1.67
-0.95
-2.81
-0.45
Selling, general and administrative
3.44
3.16
7.13
4.88
Operating expenses
3.44
5.09
7.54
6.7
Operating income
-1.77
-6.04
-10.3
-7.15
Interest expense
0.74
0.85
2.3
3.38
Interest income
0.08
0
Other non-operating income
0.03
-1.08
-3.3
-4.83
Pre-tax income
-2.53
-7.12
-13.6
-12
Income tax
-0.07
0.22
0.01
0
Net income
-2.46
-7.34
-13.7
-12
EBITDA
-1.63
-5.87
-10.2
-6.85
EPS, basic
-4.49
-9.88
-11.88
-0.81
EPS, diluted
-4.49
-9.88
-11.88
-0.81
Shares, basic (weighted)
0.56
0.74
1.15
14.9
Shares, diluted (weighted)
0.56
0.74
1.15
14.9
Balance sheet
FY2023
FY2023
FY2024
FY2025
Cash and equivalents
0.81
0.22
0.42
0.1
Receivables
3.56
1.24
1.83
0.15
Inventory
8.8
5.05
1.78
Other current assets
0.13
0.14
0.15
0.1
Total current assets
13.4
7.41
5.17
0.96
Property, plant and equipment
4.59
4.41
4.25
18.4
Lease right-of-use assets
0.97
0.5
0.47
0.13
Goodwill
1.02
0.83
Total assets
20.8
14.2
11.3
20.4
Accounts payable
2.34
8.03
10.4
9.68
Deferred revenue
0.81
0.12
0.14
0.05
Short-term debt
0.11
0.27
2.67
4.19
Total current liabilities
16.7
14.8
19.8
23.3
Long-term debt
2.97
5.98
5.68
5.4
Lease liabilities
0.54
0.16
0.21
0.04
Total liabilities
20.2
20.9
25.7
31.7
Total debt
0.15
0.11
0.08
5.4
Paid-in capital
1.53
1.53
10.4
24
Retained earnings
-0.91
-8.25
-24.7
-36.8
Other comprehensive income
-0
-0
-0
-0
Shareholders' equity
0.62
-6.72
-14.3
-12.7
Total equity
0.62
-6.72
-14.3
-12.7
Total liabilities and equity
20.8
14.2
11.3
20.4
Shares outstanding
0.74
0.74
2.45
113
Cash flow statement
FY2023
FY2023
FY2024
FY2025
Net income
-2.46
-7.34
-13.7
-12
Depreciation and amortization
0.14
0.16
0.16
0.3
Stock-based compensation
1.41
0.34
Deferred income tax
-0.14
0.22
Change in receivables
-3.53
0.25
-1.67
0.83
Change in inventory
3.09
2.49
0.95
1.23
Change in payables
0.08
-1.15
2.61
-0.8
Cash from operations
-2.45
-1.68
-5.93
-3.99
Capital expenditures
-0.05
Purchases of investments
-0.3
Cash from investing
-0.27
-0.44
-0.04
-0.86
Debt issued
3.34
Debt repaid
-0.09
-0.17
Stock issued
0.39
1
0.17
Cash from financing
2.22
1.53
6.17
4.53
Exchange rate effect
-0
0
0
0
Net change in cash
-0.5
-0.59
0.2
-0.32
Free cash flow
-2.51
Interest paid
0.69
0.77
1.28
0.39
Income taxes paid
0.41
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.00 on October 16, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-92.1%
Gross profit / revenue.
Operating margin
-1,045.0%
Operating income / revenue.
EBITDA margin
-985.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1,052.0%
Pre-tax income / revenue.
Net margin
-1,052.0%
Net income / revenue.
Operating cash flow margin
-737.9%
Cash from operations / revenue.
Return on assets (ROA)
-33.1%
Net income / average total assets.
SG&A / revenue
688.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
53.4%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
60.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-81.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-54.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
80.4%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-0.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
1,199.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
199.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.07x
Current assets / current liabilities.
Quick ratio
0.01x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Debt / assets
34.5%
Total debt / total assets.
Liabilities / assets
136.2%
Total liabilities / total assets.
Net debt
$7.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.02
Cash from operations / diluted weighted shares.
Book value per share
-$0.03
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.27x
Market cap / revenue.
EV/Sales
11.2x
Enterprise value / revenue.
Earnings yield
-3,913.0%
Net income / market cap (the inverse of P/E).
What was Nature's Miracle Holding Inc.'s revenue in fiscal 2025?
Nature's Miracle Holding Inc. reported revenue of $1.7M for fiscal 2025, 81.2% lower than the year before.
Was Nature's Miracle Holding Inc. profitable in fiscal 2025?
No. It reported a net loss of $12.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.